Janux Therapeutics, Inc. (JANX) Shareholders’ equity 2020–2025
Janux Therapeutics, Inc. (JANX) shareholders’ equity at each fiscal year-end, per SEC filings.
$956.8MFY2025 · since FY2020: -$14.6M → $956.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $956.8M | -6.4% |
| FY2024 | $1.0B | +197.0% |
| FY2023 | $344.3M | +7.4% |
| FY2022 | $320.7M | -12.4% |
| FY2021 | $366.3M | +2602.6% |
| FY2020 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice